Interstitial lung abnormalities are associated with increased mortality in smokers
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Interstitial lung abnormalities are associated with increased mortality in smokers. / Hoyer, Nils; Wille, Mathilde M W; Thomsen, Laura H; Wilcke, Torgny; Dirksen, Asger; Pedersen, Jesper H; Saghir, Zaigham; Ashraf, Haseem; Shaker, Saher B.
I: Respiratory Medicine, Bind 136, 2018, s. 77-82.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Interstitial lung abnormalities are associated with increased mortality in smokers
AU - Hoyer, Nils
AU - Wille, Mathilde M W
AU - Thomsen, Laura H
AU - Wilcke, Torgny
AU - Dirksen, Asger
AU - Pedersen, Jesper H
AU - Saghir, Zaigham
AU - Ashraf, Haseem
AU - Shaker, Saher B
N1 - Copyright © 2018 The Authors. Published by Elsevier Ltd.. All rights reserved.
PY - 2018
Y1 - 2018
N2 - OBJECTIVE: The aim of this study was to investigate whether smokers with incidental findings of interstitial lung abnormalities have an increased mortality during long-term follow-up, and review the contributing causes of death.METHODS: Baseline CT scans of 1990 participants from the Danish Lung Cancer Screening Trial were qualitatively assessed for predefined interstitial lung abnormalities of any severity. Inclusion criteria for this lung cancer screening trial included current or former smoking, > 20 pack-years, and age 50-70 years. Patients were followed up for up to 12 years.RESULTS: We found interstitial lung abnormalities in 332 participants (16.7%). Interstitial lung abnormalities were associated with increased all-cause mortality in the full cohort (HR: 2.0, 95% CI: 1.4-2.7, P < 0.001) and in lung cancer-free participants (HR: 1.6, 95% CI: 1.1-2.4, P = 0.007). The findings were associated with death from lung cancer (HR: 3.2, 95% CI: 1.7-6.2, P < 0.001) and non-pulmonary malignancies (HR: 2.1, 95% CI: 1.1-4.0, P = 0.02). Participants with fibrotic and non-fibrotic interstitial lung abnormalities had similar survival.CONCLUSION: Interstitial lung abnormalities were common in this lung cancer screening population of relatively healthy smokers and were associated with mortality regardless of the interstitial morphological phenotype. The increased mortality was partly due to an association with lung cancer and non-pulmonary malignancies.
AB - OBJECTIVE: The aim of this study was to investigate whether smokers with incidental findings of interstitial lung abnormalities have an increased mortality during long-term follow-up, and review the contributing causes of death.METHODS: Baseline CT scans of 1990 participants from the Danish Lung Cancer Screening Trial were qualitatively assessed for predefined interstitial lung abnormalities of any severity. Inclusion criteria for this lung cancer screening trial included current or former smoking, > 20 pack-years, and age 50-70 years. Patients were followed up for up to 12 years.RESULTS: We found interstitial lung abnormalities in 332 participants (16.7%). Interstitial lung abnormalities were associated with increased all-cause mortality in the full cohort (HR: 2.0, 95% CI: 1.4-2.7, P < 0.001) and in lung cancer-free participants (HR: 1.6, 95% CI: 1.1-2.4, P = 0.007). The findings were associated with death from lung cancer (HR: 3.2, 95% CI: 1.7-6.2, P < 0.001) and non-pulmonary malignancies (HR: 2.1, 95% CI: 1.1-4.0, P = 0.02). Participants with fibrotic and non-fibrotic interstitial lung abnormalities had similar survival.CONCLUSION: Interstitial lung abnormalities were common in this lung cancer screening population of relatively healthy smokers and were associated with mortality regardless of the interstitial morphological phenotype. The increased mortality was partly due to an association with lung cancer and non-pulmonary malignancies.
KW - Age Distribution
KW - Aged
KW - Cause of Death
KW - Denmark/epidemiology
KW - Female
KW - Forced Expiratory Volume/physiology
KW - Humans
KW - Lung Diseases, Interstitial/mortality
KW - Lung Neoplasms/mortality
KW - Male
KW - Middle Aged
KW - Prospective Studies
KW - Registries
KW - Smoking/mortality
KW - Tomography, X-Ray Computed
KW - Vital Capacity/physiology
U2 - 10.1016/j.rmed.2018.02.001
DO - 10.1016/j.rmed.2018.02.001
M3 - Journal article
C2 - 29501250
VL - 136
SP - 77
EP - 82
JO - Respiratory Medicine
JF - Respiratory Medicine
SN - 0954-6111
ER -
ID: 213154462